Clobuzarit - PMC

Inge C.M. van Eekeren, Stefan Clockaerts, Yvonne M. Bastiaansen-Jenniskens, Eric Lubberts, Jan A.N. Verhaar, Gerjo J.V.M. van Osch, Sita M. Bierma-Zeinstra

Ther Adv Musculoskelet Dis. 2013 Feb; 5(1): 33–44. doi: 10.1177/1759720X12468659

PMCID:: PMC3582306

Article PDF–603K

Select item 29978004.

Fibrates, glitazones, and peroxisome proliferator-activated receptors

Fanny Lalloyer, Bart Staels

Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2010 Dec 7.

Published in final edited form as: Arterioscler Thromb Vasc Biol. 2010 May; 30(5): 894–899. doi: 10.1161/ATVBAHA.108.179689

PMCID:: PMC2997800

Article

Select item 13682395.

Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

T Pullar

Br J Clin Pharmacol. 1990 Oct; 30(4): 501–510. doi: 10.1111/j.1365-2125.1990.tb03807.x

PMCID:: PMC1368239

Summary Page Browse PDF–1.3M

Select item 10012086.

Progression of radiological changes in rheumatoid arthritis.

D L Scott, K A Grindulis, G R Struthers, B L Coulton, A J Popert, P A Bacon

Ann Rheum Dis. 1984 Feb; 43(1): 8–17. doi: 10.1136/ard.43.1.8

PMCID:: PMC1001208

Summary Page Browse PDF–1.3M

Select item 15194427.

Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.

B G Lake, J G Evans, M E Cunninghame, R J Price

Environ Health Perspect. 1993 Dec; 101(Suppl 5): 241–247. doi: 10.1289/ehp.93101s5241

PMCID:: PMC1519442

Summary Page Browse PDF–1.1M

Select item 14746728.

Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.

C Rhodes, T C Orton, I S Pratt, P L Batten, H Bratt, S J Jackson, C R Elcombe

Environ Health Perspect. 1986 Mar; 65: 299–307. doi: 10.1289/ehp.8665299

PMCID:: PMC1474672

Summary Page Browse PDF–1.6M

Select item 14009589.

Oxicams: Relative safety and anti-injury effects in rats

M. W. Whitehouse

Br J Clin Pharmacol. 1986; 22(Suppl 2): 111S–116S. doi: 10.1111/j.1365-2125.1986.tb02990.x

PMCID:: PMC1400958

Summary Page Browse PDF–684K

Select item 100408310.

Drug toxicity.

H A Bird

Ann Rheum Dis. 1990 May; 49(5): 331–336. doi: 10.1136/ard.49.5.331

PMCID:: PMC1004083

Summary Page Browse PDF–1.3M

Select item 140095911.

Experience with isoxicam and catabolin

H. Sheppeard, K. G. Couchman

Br J Clin Pharmacol. 1986; 22(Suppl 2): 121S–124S. doi: 10.1111/j.1365-2125.1986.tb02992.x

PMCID:: PMC1400959

Summary Page Browse PDF–441K

Select item 147429412.

Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.

C R Elcombe, A M Mitchell

Environ Health Perspect. 1986 Dec; 70: 211–219. doi: 10.1289/ehp.8670211

PMCID:: PMC1474294

Summary Page Browse PDF–2.6M

Select item 185868913.

Clofibrate treatment in pigs: Effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents

Sebastian Luci, Beatrice Giemsa, Gerd Hause, Holger Kluge, Klaus Eder

BMC Pharmacol. 2007; 7: 6. Published online 2007 Apr 16. doi: 10.1186/1471-2210-7-6

PMCID:: PMC1858689

Article PDF–393K

Supplemental Content

Filter your results:

All (13)
NIH grants (0)
Embargoed (0)

Manage Filters

Find related data

Search details

Recent activity

Clear Turn Off Turn On

Clobuzarit (13)
PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

PMC Full-Text Search Results

Items: 13

Display Settings:

Send to:

Supplemental Content

Find related data

Search details

Recent activity